NCT04796597View on ClinicalTrials.gov

Early Feasibility Study on Epios Leads

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

July 7, 2023

Study Completion Date

November 2, 2023

Conditions
Epilepsy
Interventions
DEVICE

Subcutaneous implantation of Epios sub-scalp leads

The sub-scalp Epios Leads will be implanted by a trained neurosurgeon and will provide epicranial EEG recording of specific cortical areas identified by the neurologist.

Trial Locations (1)

3007

Universitätklinik für Neurologie, Inselspital, Bern University, Bern

All Listed Sponsors
lead

Wyss Center for Bio and Neuroengineering

OTHER

NCT04796597 - Early Feasibility Study on Epios Leads | Biotech Hunter | Biotech Hunter